Overview of cellular electrophysiological actions of vasopressin
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
The nonapeptide vasopressin acts both as a hormone and as a neurotransmitter/neuromodulator. As a hormone, its target organs include kidney, blood vessels, liver, platelets and anterior pituitary. As a neurotransmitter/neuromodulator, vasopressin plays a role in autonomic functions, such as cardiovascular regulation and temperature regulation and is involved in complex behavioral and cognitive functions, such as sexual behavior, pair-bond formation and social recognition. At the neuronal level, vasopressin acts by enhancing membrane excitability and by modulating synaptic transmission. The present review will focus on the electrophysiological effects of vasopressin at the cellular level. A large proportion of the experiments summarized here have been performed in in vitro systems, especially in brain and spinal cord slices of the rat. Vasopressin exerts a powerful excitatory action on motoneurons of young rats and mice. It acts by generating a cationic inward current and/or by reducing a potassium conductance. In addition, vasopressin enhances the inhibitory synaptic input to motoneurons. By virtue of these actions, vasopressin may regulate the functioning of neuronal networks involved in motor control. In the amygdala, vasopressin can directly excite a subpopulation of neurons, whereas oxytocin, a related neuropeptide, can indirectly inhibit these same neurons. In the lateral septum, vasopressin exerts a similar dual action: it excites directly a neuronal subpopulation, but causes indirect inhibition of virtually all lateral septal neurons. The actions of vasopressin in the amygdala and lateral septum may represent at least part of the neuronal substrate by which vasopressin influences fear and anxiety-related behavior and social recognition, respectively. Central vasopressin can modulate cardiovascular parameters by causing excitation of spinal sympathetic preganglionic neurons, by increasing the inhibitory input to cardiac parasympathetic neurons in the nucleus ambiguus, by depressing the excitatory input to parabrachial neurons, or by inhibiting glutamate release at solitary tract axon terminals. By acting in or near the hypothalamic supraoptic nucleus, vasopressin can influence magnocellular neuron activity, suggesting that the peptide may exert some control on its own release at neurohypophyseal axon terminals. The central actions of vasopressin are mainly mediated by receptors of the V(1A) type, although recent studies have also reported the presence of vasopressin V(1B) receptors in the brain. Major unsolved problems are: (i) what is the transduction pathway activated following stimulation of central vasopressin V(1A) receptors? (ii) What is the precise nature of the cation channels and/or potassium channels operated by vasopressin? (iii) Does vasopressin, by virtue of its second messenger(s), interfere with other neurotransmitter/neuromodulator systems? In recent years, information concerning the mechanism of action of vasopressin at the neuronal level and its possible role and function at the whole-animal level has been accumulating. Translation of peptide actions at the cellular level into autonomic, behavioral and cognitive effects requires an intermediate level of integration, i.e. the level of neuronal circuitry. Here, detailed information is lacking. Further progress will probably require the introduction of new techniques, such as targeted in vivo whole-cell recording, large-scale recordings from neuronal ensembles or in vivo imaging in small animals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxytocin increases trust in humans
Kosfeld, M., Heinrichs, M., Zak, P. J., Fischbacher, U., & Fehr, E. (2005) · Nature · doi:10.1038/nature03701 · Cited by 3,690
Large-scale recording of neuronal ensembles
Buzsáki, G. (2004) · Nature Neuroscience · doi:10.1038/nn1233 · Cited by 1,875 · cited 2×
“…recordings (Lee et al., 2006;Margrie et al., 2003) (ii) large-scale recordings from neuronal ensembles, performed either in vitro or in vivo (Buzsaki, 2004); (iii) in vivo light-dependent activation of selected neuronal channels (Arenkiel et al., 2007; Szobota et al., 2007); (iv) in vivo…”
BackgroundThe neurobiology of pair bonding.
Young, L. J., & Wang, Z. (2004) · Nature Neuroscience · doi:10.1038/nn1327 · Cited by 1,523
The neural correlates of maternal and romantic love
Bartels, A., & Zeki, S. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2003.11.003 · Cited by 1,497 · cited 1×
“Interestingly, some evidence suggests that the vasopressinergic and the related oxytocinergic systems of the brain may play a critical role in the establishment of social and affective bonds in humans (Bartels and Zeki, 2004; Fries et al., 2005; Kosfeld et al., 2005; Storm and Tecott, 2005).”
BackgroundLandgraf, R., & Neumann, I. D. (2004) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2004.05.001 · Cited by 1,059
Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin
Gillies, G. E., Linton, E. A., & Lowry, P. J. (1982) · Nature · doi:10.1038/299355a0 · Cited by 965 · cited 2×
“Stress stimulates the release of vasopressin from neurons in the parvocellular division of the paraventricular nucleus into the pituitary portal circulation, where vasopressin potentiates the effect of corticotropin-releasing factor (CRF) on adrenocorticotropin hormone (ACTH) release (Gillies et al., 1982).”
BackgroundDendritic peptide release and peptide-dependent behaviours
Ludwig, M., & Leng, G. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1845 · Cited by 945 · cited 1×
“…can be released from the soma and dendrites of magnocellular neurons and that this locally released vasopressin exerts an autoregulatory action on the activity of magnocellular neurons (Gouzenes et al., 1998; Landgraf and Neumann, 2004; Ludwig and Leng, 1997, 2006; Ludwig and Pittman, 2003).”
BackgroundVasopressin and Oxytocin Excite Distinct Neuronal Populations in the Central Amygdala
Huber, D., Veinante, P., & Stoop, R. (2005) · Science · doi:10.1126/science.1105636 · Cited by 804
Arenkiel, B. R., Peca, J., Davison, I. G., Feliciano, C., Deisseroth, K., Augustine, G. J., Ehlers, M. D., & Feng, G. (2007) · Neuron · doi:10.1016/j.neuron.2007.03.005 · Cited by 755
Connections of the rat lateral septal complex 1Published on the World Wide Web on 2 June 1997. 1
Risold, P. Y., & Swanson, L. W. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00009-x · Cited by 671
Lim, M. M., Wang, Z., Olazábal, D. E., Ren, X., Terwilliger, E. F., & Young, L. J. (2004) · Nature · doi:10.1038/nature02539 · Cited by 628
Fries, A. B. W., Ziegler, T. E., Kurian, J. R., Jacoris, S., & Pollak, S. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504767102 · Cited by 570
Bielsky, I. F., Hu, S.-B., Szegda, K. L., Westphal, H., & Young, L. J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300360 · Cited by 531
Lolait, S. J., O'Carroll, A.-M., McBride, O. W., Konig, M., Morel, A., & Brownstein, M. J. (1992) · Nature · doi:10.1038/357336a0 · Cited by 524 · cited 2×
“Rat and human vasopressin V1A receptors present in liver or blood vessels smooth muscle have been cloned and sequenced (Hirasawa et al., 1994; Morel et al., 1992; Thibonnier et al., 1994), as have been renal vasopressin V2 receptors (Birnbaumer et al., 1992; Lolait et al., 1992).”
BackgroundYoung, L. J., Nilsen, R., Waymire, K. G., MacGregor, G. R., & Insel, T. R. (1999) · Nature · doi:10.1038/23475 · Cited by 488 · cited 2×
“, 2000), pair-bond formation (Lim et al., 2004; Young et al., 1999; Young andWang, 2004), fatherhood behavior (Kozorovitskiy et al.”
BackgroundMolecular cloning and expression of a rat Via arginine vasopressin receptor
Morel, A., O'Carroll, A.-M., Brownstein, M. J., & Lolaft, S. J. (1992) · Nature · doi:10.1038/356523a0 · Cited by 477
Griebel, G., Simiand, J., Serradeil-Le Gal, C., Wagnon, J., Pascal, M., Scatton, B., Maffrand, J.-P., & Soubrié, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092012099 · Cited by 471 · cited 1×
“The vasopressin V1B receptor antagonist SSR149415 appears to exert anxiolytic- and antidepressant-like effects (Griebel et al., 2002; Stemmelin et al., 2005).”
BackgroundDendrites of hypothalamic magnocellular neurons release neurohypophysial peptides by exocytosis
Pow, D. V., & Morris, J. F. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90091-2 · Cited by 446 · cited 1×
“Ultrastructural evidence indicates that dense core vesicles are present in the soma and dendrites of supraoptic magnocellular neurons and that exocytose can occur (Pow and Morris, 1989).”
BackgroundTribollet, E., Barberis, C., Jard, S., Dubois-Dauphin, M., & Dreifuss, J. J. (1988) · Brain Research · doi:10.1016/0006-8993(88)91437-0 · Cited by 442 · cited 5×
“The lateral septal area is rich in vasopressin V1A receptors (Freund-Mercier et al., 1988b; Tribollet et al., 1988; Tribollet, 1992).”
BackgroundInfluentialVasopressin and oxytocin receptors in the central nervous system
Tribollet, E., & Barberis, C. (1996) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v10.i1.60 · Cited by 399 · cited 2×
“In the brain, vasopressin exerts its effects mainly by binding to vasopressin V1A receptors (Barberis and Tribollet, 1996; Raggenbass, 2001; Tribollet, 1992).”
BackgroundVasopressin V1b receptor knockout reduces aggressive behavior in male mice
Wersinger, S. R., Ginns, E. I., O'Carroll, A.-M., Lolait, S. J., & Young III, W. S. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001195 · Cited by 397
Young (1999) · doi:10.1038/23650 · Cited by 389
Bielsky, I. F., Hu, S.-B., Ren, X., Terwilliger, E. F., & Young, L. J. (2005) · Neuron · doi:10.1016/j.neuron.2005.06.031 · Cited by 367
Landgraf, R., Gerstberger, R., Montkowski, A., Probst, J., Wotjak, C., Holsboer, F., & Engelmann, M. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-06-04250.1995 · Cited by 341
Structural bases of vasopressin/oxytocin receptor function
Barberis, C., Mouillac, B., & Durroux, T. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1560223 · Cited by 311
Vaccari, C., Lolait, S. J., & Ostrowski, N. L. (1998) · Endocrinology · doi:10.1210/endo.139.12.6382 · Cited by 308
Caffé, A. R., van Leeuwen, F. W., & Luiten, P. G. M. (1987) · Journal of Comparative Neurology · doi:10.1002/cne.902610206 · Cited by 286
Chamberlin, N. L., & Saper, C. B. (1992) · Journal of Comparative Neurology · doi:10.1002/cne.903260207 · Cited by 222 · cited 1×
“It contains at least two neuronal systems that are involved in cardiovascular control in an opposite way, the first eliciting pressor-tachycardic responses, the second eliciting depressor-bradycardic responses (Chamberlin and Saper, 1992).”
BackgroundYoung, W. S., Li, J., Wersinger, S. R., & Palkovits, M. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.08.040 · Cited by 222 · cited 6×
“Recently, the presence of vasopressin V1B receptors in some central structures has also been reported (Hernando et al., 2001; Lolait et al., 1995; Stemmelin et al., 2005; Vaccari et al., 1998; Young et al., 2006).”
BackgroundMethodResultInfluentialNeuroendocrine basis of social recognition
Winslow, J. T., & Insel, T. R. (2004) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2004.03.009 · Cited by 180
Fatherhood affects dendritic spines and vasopressin V1a receptors in the primate prefrontal cortex
Kozorovitskiy, Y., Hughes, M., Lee, K., & Gould, E. (2006) · Nature Neuroscience · doi:10.1038/nn1753 · Cited by 158 · cited 2×
“…processes (Alescio-Lautier et al., 2000), pair-bond formation (Lim et al., 2004; Young et al., 1999; Young andWang, 2004), fatherhood behavior (Kozorovitskiy et al., 2006), anxiety and depression (Bielsky et al., 2004; Holmes et al., 2003; Landgraf, 2005) and social recognition (Bielsky et…”
BackgroundVasopressin Inhibits Glutamate Release via Two Distinct Modes in the Brainstem
Bailey, T. W., Jin, Y.-H., Doyle, M. W., Smith, S. M., & Andresen, M. C. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.5176-05.2006 · Cited by 112 · cited 3×
“4): (i) by reducing the excitatory postsynaptic current amplitude; (ii) by inducing synaptic failures (Bailey et al., 2006).”
BackgroundStemmelin, J., Lukovic, L., Salome, N., & Griebel, G. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300562 · Cited by 112 · cited 5×
“Recently, the presence of vasopressin V1B receptors in some central structures has also been reported (Hernando et al., 2001; Lolait et al., 1995; Stemmelin et al., 2005; Vaccari et al., 1998; Young et al., 2006).”
BackgroundResultInfluentialChen, X., & Pittman, Q. J. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.82.4.1689 · Cited by 17 · cited 2×
“Nystatin patch clamp recordings obtained from parabrachial neurons in brainstem slices revealed an effect of vasopressin on glutamatergic transmission in this nucleus (Chen and Pittman, 1999).”
Background
Cited by
Joëls, M., & Baram, T. Z. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2632 · Cited by 1,521
“In the brain as a whole, vasopressin acts on a wide array of neuron”
BackgroundOxytocin: The Great Facilitator of Life
Lee, H.-J., Macbeth, A. H., Pagani, J., & Young, W. S. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.04.001 · Cited by 1,037
Neuropeptide Transmission in Brain Circuits
van den Pol, A. N. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.014 · Cited by 810
Neuromodulation by Oxytocin and Vasopressin
Stoop, R. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.025 · Cited by 506
Vasopressin V1a and V1b Receptors: From Molecules to Physiological Systems
Koshimizu, T.-A., Nakamura, K., Egashira, N., Hiroyama, M., Nonoguchi, H., & Tanoue, A. (2012) · Physiological Reviews · doi:10.1152/physrev.00035.2011 · Cited by 407
Metadata
- Authors
- Raggenbass, M.
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2008-04
- Volume
- 583
- Issue
- 2-3
- Pages
- 243-254
- ISSN
- 0014-2999 (ISSN-L)
- OpenAlex
- W1996622763
- Cited by
- 101
- References
- 34
- FWCI
- 10.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.